Matthias A. Englbrecht
Greven, MV, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications
Renewed increase in new Janus kinase inhibitor prescriptions : Analysis of the German RHADAR registry
Journal: Zeitschrift fur Rheumatologie
Published: June 18, 2025
Potential of digital applications for self-management and other outcomes in inflammatory rheumatic diseases: a systematic literature review.
Journal: Frontiers in medicine
Published: April 23, 2025
Discordance between patient and physician reported global disease activity in PsA is associated with mental health-a cross-sectional analysis.
Journal: Rheumatology international
Published: April 17, 2025
RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings.
Journal: Rheumatology international
Published: January 07, 2025
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study.
Journal: The Lancet. Rheumatology
Published: October 28, 2024
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.
Journal: Rheumatology international
Published: October 21, 2024
Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network.
Journal: Rheumatology international
Published: March 31, 2024
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database.
Journal: Frontiers in immunology
Published: March 04, 2024
Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis.
Journal: Medical decision making : an international journal of the Society for Medical Decision Making
Published: January 19, 2024
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial.
Journal: Journal of medical Internet research
Published: December 15, 2023
Indistinguishability of Identical Bosons from a Quantum Information Theory Perspective.
Journal: Physical review letters
Published: August 22, 2023
Last Updated: 09/26/2026